nr2f1 Search Results


93
MedChemExpress nr2f1 agonist 1
The protein level of <t>NR2F1</t> is increased in the ASC model. (A) The anesthetized and dilated mice were positioned beneath a microscope for the ASC modeling procedure. (B) Cataract lesions in control and ASC mice using a slit lamp. (C) Hematoxylin and eosin staining in lens section of control and ASC mice. Scale bar, 100 μm. (D) Masson staining of the two groups. Scale bar, 100 μm. (E) The immunofluorescence results of FN1 and VIM in lens slides of control and ASC groups. Scale bar, 50 μm. (F, G) The protein expression and quantification of apoptosis-related markers BAX and CASP3 in control and ASC groups. n = 3 per group; mean ± standard deviation; ∗∗ p < 0.01; unpaired student's t -test. (H, I) The protein level and quantitative chart of NR2F1 in the two groups mentioned above. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. NR2F1, nuclear receptor subfamily 2 group F member 1; ASC, anterior subcapsular cataract; FN1, fibronectin 1; VIM, vimentin; BAX, Bcl-2-associated X; CASP3, caspase 3.
Nr2f1 Agonist 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/NR2F1+agonist+1/pmc12242405-36-0-4
Average 93 stars, based on 1 article reviews
nr2f1 agonist 1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
R&D Systems coup tfi
The protein level of <t>NR2F1</t> is increased in the ASC model. (A) The anesthetized and dilated mice were positioned beneath a microscope for the ASC modeling procedure. (B) Cataract lesions in control and ASC mice using a slit lamp. (C) Hematoxylin and eosin staining in lens section of control and ASC mice. Scale bar, 100 μm. (D) Masson staining of the two groups. Scale bar, 100 μm. (E) The immunofluorescence results of FN1 and VIM in lens slides of control and ASC groups. Scale bar, 50 μm. (F, G) The protein expression and quantification of apoptosis-related markers BAX and CASP3 in control and ASC groups. n = 3 per group; mean ± standard deviation; ∗∗ p < 0.01; unpaired student's t -test. (H, I) The protein level and quantitative chart of NR2F1 in the two groups mentioned above. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. NR2F1, nuclear receptor subfamily 2 group F member 1; ASC, anterior subcapsular cataract; FN1, fibronectin 1; VIM, vimentin; BAX, Bcl-2-associated X; CASP3, caspase 3.
Coup Tfi, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/Human+COUP-TF+I%2FNR2F1+Antibody+(Clone+H8132)/pmc05917473-56-44-74
Average 94 stars, based on 1 article reviews
coup tfi - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Proteintech 1 ap
The protein level of <t>NR2F1</t> is increased in the ASC model. (A) The anesthetized and dilated mice were positioned beneath a microscope for the ASC modeling procedure. (B) Cataract lesions in control and ASC mice using a slit lamp. (C) Hematoxylin and eosin staining in lens section of control and ASC mice. Scale bar, 100 μm. (D) Masson staining of the two groups. Scale bar, 100 μm. (E) The immunofluorescence results of FN1 and VIM in lens slides of control and ASC groups. Scale bar, 50 μm. (F, G) The protein expression and quantification of apoptosis-related markers BAX and CASP3 in control and ASC groups. n = 3 per group; mean ± standard deviation; ∗∗ p < 0.01; unpaired student's t -test. (H, I) The protein level and quantitative chart of NR2F1 in the two groups mentioned above. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. NR2F1, nuclear receptor subfamily 2 group F member 1; ASC, anterior subcapsular cataract; FN1, fibronectin 1; VIM, vimentin; BAX, Bcl-2-associated X; CASP3, caspase 3.
1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/NR2F1+Antibody/pm39260368-270-64-62
Average 93 stars, based on 1 article reviews
1 ap - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Addgene inc lambda
Kinase domain constructs with yields >2 μ g/mL culture for 96-kinase expression screen. Kinases are listed by Uniprot designation and whether they were co-expressed with <t> Lambda </t> or truncated YopH164 phosphatase. Yield (determined by Caliper GX II quantitation of the expected size band) reported in μ g/mL culture, where total eluate volume was 120 μ L from 900 μ L bacterial culture. Yields are shaded green (yield > 12 μ g/mL), yellow (12 > yield > 7 μ g/mL) and orange (yield <7 μ g/mL); kinase domain constructs with yields that were undetectable or < 2 μ g/mL are not listed. ‡ denotes that the second kinase domain of KS6A1_HUMAN was expressed; all other kinases were the first or only kinase domain occurring in the ORF. Construct boundaries are listed in UniProt residue numbering for the UniProt canonical isoform. An interactive table of expression yields and corresponding constructs is available at http://choderalab.org/kinome-expression
Lambda, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/pSMP-NR2F1_3+(Plasmid+%2336364)/pmc06081246-8-7-4
Average 90 stars, based on 1 article reviews
lambda - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti nr2f2 antibody
Kinase domain constructs with yields >2 μ g/mL culture for 96-kinase expression screen. Kinases are listed by Uniprot designation and whether they were co-expressed with <t> Lambda </t> or truncated YopH164 phosphatase. Yield (determined by Caliper GX II quantitation of the expected size band) reported in μ g/mL culture, where total eluate volume was 120 μ L from 900 μ L bacterial culture. Yields are shaded green (yield > 12 μ g/mL), yellow (12 > yield > 7 μ g/mL) and orange (yield <7 μ g/mL); kinase domain constructs with yields that were undetectable or < 2 μ g/mL are not listed. ‡ denotes that the second kinase domain of KS6A1_HUMAN was expressed; all other kinases were the first or only kinase domain occurring in the ORF. Construct boundaries are listed in UniProt residue numbering for the UniProt canonical isoform. An interactive table of expression yields and corresponding constructs is available at http://choderalab.org/kinome-expression
Anti Nr2f2 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/NR2F2+Rabbit+pAb/pmc12454641__41467_2025_64035_MOESM2_ESM-94-145-147
Average 94 stars, based on 1 article reviews
anti nr2f2 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
OriGene shrna against mouse nr2f1 gene
Figure 1. <t>NR2F1</t> is downstream of p38 and HER2 signaling in ECCs. A. QPCR and percentage of cells/duct with nuclear NR2F1 shown by IHC from mammary glands of MMTV-HER2 females treated with SB203580. N=2 mice/condition. B. Percentage of HER2 positive+ cells per field of view (FOV) that has either NR2F1HIGH
Shrna Against Mouse Nr2f1 Gene, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/Nr2f1+Mouse+shRNA+Plasmid/pm35471456-64-5-10
Average 90 stars, based on 1 article reviews
shrna against mouse nr2f1 gene - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
OriGene coup tfii v2 cat no 4453629 plasmids
Figure 1. <t>NR2F1</t> is downstream of p38 and HER2 signaling in ECCs. A. QPCR and percentage of cells/duct with nuclear NR2F1 shown by IHC from mammary glands of MMTV-HER2 females treated with SB203580. N=2 mice/condition. B. Percentage of HER2 positive+ cells per field of view (FOV) that has either NR2F1HIGH
Coup Tfii V2 Cat No 4453629 Plasmids, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/COUP+TF1+(NR2F1)+(NM_005654)+Human+3'+UTR+Clone/pm35348189-26-5-12
Average 90 stars, based on 1 article reviews
coup tfii v2 cat no 4453629 plasmids - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
OriGene rabbit polyclonal anti coup tfii antibody
Figure 1. Immunohistochemical analysis of Shh pathway expression in human brain AVMs. Representative images of human brain AVMs and control brain vessels. Cells in the intimal layer of AVMs are strongly immunopositive for Shh and Gli1. <t>COUP-TFII</t> immunopositive cells are detectable in the intimal and medial layers of AVMs. Control brain vessels are negative in terms of Shh, Gli1, and COUP-TFII expression. Shh: Sonic hedgehog.
Rabbit Polyclonal Anti Coup Tfii Antibody, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/COUP+TF1+(NR2F1)+Rabbit+Polyclonal+Antibody/10__1177_slash_0271678x20912405-57-29-33
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti coup tfii antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
R&D Systems nr2f1
Figure 1. Immunohistochemical analysis of Shh pathway expression in human brain AVMs. Representative images of human brain AVMs and control brain vessels. Cells in the intimal layer of AVMs are strongly immunopositive for Shh and Gli1. <t>COUP-TFII</t> immunopositive cells are detectable in the intimal and medial layers of AVMs. Control brain vessels are negative in terms of Shh, Gli1, and COUP-TFII expression. Shh: Sonic hedgehog.
Nr2f1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/Human+COUP-TF+I%2FNR2F1+Antibody+(Clone+H8132)/pm30982769-302-30-33
Average 94 stars, based on 1 article reviews
nr2f1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
R&D Systems mouse anti coup tfi igg 2a
Figure 1. Immunohistochemical analysis of Shh pathway expression in human brain AVMs. Representative images of human brain AVMs and control brain vessels. Cells in the intimal layer of AVMs are strongly immunopositive for Shh and Gli1. <t>COUP-TFII</t> immunopositive cells are detectable in the intimal and medial layers of AVMs. Control brain vessels are negative in terms of Shh, Gli1, and COUP-TFII expression. Shh: Sonic hedgehog.
Mouse Anti Coup Tfi Igg 2a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/COUP-TF+I%2FNR2F1+Antibody+(1A4)/pmc06220585-55-38-43
Average 91 stars, based on 1 article reviews
mouse anti coup tfi igg 2a - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp nr2f1 mm00657937 m1
Figure 1. Immunohistochemical analysis of Shh pathway expression in human brain AVMs. Representative images of human brain AVMs and control brain vessels. Cells in the intimal layer of AVMs are strongly immunopositive for Shh and Gli1. <t>COUP-TFII</t> immunopositive cells are detectable in the intimal and medial layers of AVMs. Control brain vessels are negative in terms of Shh, Gli1, and COUP-TFII expression. Shh: Sonic hedgehog.
Gene Exp Nr2f1 Mm00657937 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nr2f1/Gene+Exp%2E+Nr2f1%2C+Mm00657937_m1/pmc05417310-21-0--1
Average 86 stars, based on 1 article reviews
gene exp nr2f1 mm00657937 m1 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


The protein level of NR2F1 is increased in the ASC model. (A) The anesthetized and dilated mice were positioned beneath a microscope for the ASC modeling procedure. (B) Cataract lesions in control and ASC mice using a slit lamp. (C) Hematoxylin and eosin staining in lens section of control and ASC mice. Scale bar, 100 μm. (D) Masson staining of the two groups. Scale bar, 100 μm. (E) The immunofluorescence results of FN1 and VIM in lens slides of control and ASC groups. Scale bar, 50 μm. (F, G) The protein expression and quantification of apoptosis-related markers BAX and CASP3 in control and ASC groups. n = 3 per group; mean ± standard deviation; ∗∗ p < 0.01; unpaired student's t -test. (H, I) The protein level and quantitative chart of NR2F1 in the two groups mentioned above. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. NR2F1, nuclear receptor subfamily 2 group F member 1; ASC, anterior subcapsular cataract; FN1, fibronectin 1; VIM, vimentin; BAX, Bcl-2-associated X; CASP3, caspase 3.

Journal: Genes & Diseases

Article Title: Autophagy-induced NR2F1 activation promotes the apoptosis of lens epithelial cells and facilitates cataract-associated fibrosis through targeting STAT3

doi: 10.1016/j.gendis.2025.101549

Figure Lengend Snippet: The protein level of NR2F1 is increased in the ASC model. (A) The anesthetized and dilated mice were positioned beneath a microscope for the ASC modeling procedure. (B) Cataract lesions in control and ASC mice using a slit lamp. (C) Hematoxylin and eosin staining in lens section of control and ASC mice. Scale bar, 100 μm. (D) Masson staining of the two groups. Scale bar, 100 μm. (E) The immunofluorescence results of FN1 and VIM in lens slides of control and ASC groups. Scale bar, 50 μm. (F, G) The protein expression and quantification of apoptosis-related markers BAX and CASP3 in control and ASC groups. n = 3 per group; mean ± standard deviation; ∗∗ p < 0.01; unpaired student's t -test. (H, I) The protein level and quantitative chart of NR2F1 in the two groups mentioned above. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. NR2F1, nuclear receptor subfamily 2 group F member 1; ASC, anterior subcapsular cataract; FN1, fibronectin 1; VIM, vimentin; BAX, Bcl-2-associated X; CASP3, caspase 3.

Article Snippet: NR2F1 agonist 1 (HY-149913, MCE) was treated at 0.5 or 1 μM concentration.

Techniques: Microscopy, Control, Staining, Immunofluorescence, Expressing, Standard Deviation

TGF-β1 mediated autophagy dysfunction resulting in an increased protein level of NR2F1. (A) The mRNA profile of NR2F1 in lens epithelial cells and fiber cells using single-cell data. (B) The mRNA level of NR2F1 in SRA01/04 cells with PBS or TGF-β1. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. (C, D) The protein expression and quantification of NR2F1 in TGF-β1-induced SRA01/04 cells. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. (E) Subcellular location of NR2F1 in PBS- or TGF-β1-treated SRA01/04 cells. Scale bar, 50 μm. (F, G) The protein level and quantification of NR2F1 in SRA01/04 cells stimulated with the autophagy inhibitor chloroquine at concentrations of 5, 10, 20, 40, and 80 μM, respectively. n = 3 per group; mean ± standard deviation; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001; one-way ANOVA. (H) Co-localization of LC3B and NR2F1 along with P62 and NR2F1 in SRA01/04 cells with TGF-β1. Scale bar, 50 μm. TGF-β1, transforming growth factor-β1; NR2F1, nuclear receptor subfamily 2 group F member 1; PBS, phosphate-buffered saline; LC3B, microtubule-associated protein 1 light-chain 3B.

Journal: Genes & Diseases

Article Title: Autophagy-induced NR2F1 activation promotes the apoptosis of lens epithelial cells and facilitates cataract-associated fibrosis through targeting STAT3

doi: 10.1016/j.gendis.2025.101549

Figure Lengend Snippet: TGF-β1 mediated autophagy dysfunction resulting in an increased protein level of NR2F1. (A) The mRNA profile of NR2F1 in lens epithelial cells and fiber cells using single-cell data. (B) The mRNA level of NR2F1 in SRA01/04 cells with PBS or TGF-β1. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. (C, D) The protein expression and quantification of NR2F1 in TGF-β1-induced SRA01/04 cells. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. (E) Subcellular location of NR2F1 in PBS- or TGF-β1-treated SRA01/04 cells. Scale bar, 50 μm. (F, G) The protein level and quantification of NR2F1 in SRA01/04 cells stimulated with the autophagy inhibitor chloroquine at concentrations of 5, 10, 20, 40, and 80 μM, respectively. n = 3 per group; mean ± standard deviation; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001; one-way ANOVA. (H) Co-localization of LC3B and NR2F1 along with P62 and NR2F1 in SRA01/04 cells with TGF-β1. Scale bar, 50 μm. TGF-β1, transforming growth factor-β1; NR2F1, nuclear receptor subfamily 2 group F member 1; PBS, phosphate-buffered saline; LC3B, microtubule-associated protein 1 light-chain 3B.

Article Snippet: NR2F1 agonist 1 (HY-149913, MCE) was treated at 0.5 or 1 μM concentration.

Techniques: Standard Deviation, Expressing, Saline

Knockdown of NR2F1 significantly attenuates fibrosis both in vivo and in vitro . (A) Adeno-associated adenovirus (AAV) was administered into the anterior chamber of mouse eyes. (B) Representative pictures of the ASC modeling group versus the negative control group under a slit lamp following AAV injection. (C) Hematoxylin and eosin staining in the two groups mentioned above. Scale bar, 100 μm. (D) Masson staining in the two groups. Scale bar, 100 μm. (E) The immunofluorescence intensity of α-SMA in the lens sections of AAV-NC and AAV-NR2F1 ASC mice. Scale bar, 50 μm. (F, G) The protein level and quantification of NR2F1 in SRA01/04 cells transfected with Sh-NC, Sh-NR2F1-1, Sh-NR2F1-2, or Sh-NR2F1-3 lentivirus. n = 3 per group; mean ± standard deviation; ∗∗∗ p < 0.001; one-way ANOVA. (H–K) The protein expression and quantitative graphs of FN1, VIM, and α-SMA in TGF-β1-induced SRA01/04 cells with Sh-NC or Sh-NR2F1. n = 3 per group; mean ± standard deviation; ∗ p < 0.05, ∗∗ p < 0.01; unpaired student's t -test. (L – N) Immunofluorescence images of FN1, VIM, and α-SMA in TGF-β1-mediated SRA01/04 cells with Sh-NC or Sh-NR2F1. Scale bar, 100 μm. NR2F1, nuclear receptor subfamily 2 group F member 1; ASC, anterior subcapsular cataract; FN1, fibronectin 1; α-SMA, α-smooth muscle actin; VIM, vimentin; TGF-β1, transforming growth factor-β1.

Journal: Genes & Diseases

Article Title: Autophagy-induced NR2F1 activation promotes the apoptosis of lens epithelial cells and facilitates cataract-associated fibrosis through targeting STAT3

doi: 10.1016/j.gendis.2025.101549

Figure Lengend Snippet: Knockdown of NR2F1 significantly attenuates fibrosis both in vivo and in vitro . (A) Adeno-associated adenovirus (AAV) was administered into the anterior chamber of mouse eyes. (B) Representative pictures of the ASC modeling group versus the negative control group under a slit lamp following AAV injection. (C) Hematoxylin and eosin staining in the two groups mentioned above. Scale bar, 100 μm. (D) Masson staining in the two groups. Scale bar, 100 μm. (E) The immunofluorescence intensity of α-SMA in the lens sections of AAV-NC and AAV-NR2F1 ASC mice. Scale bar, 50 μm. (F, G) The protein level and quantification of NR2F1 in SRA01/04 cells transfected with Sh-NC, Sh-NR2F1-1, Sh-NR2F1-2, or Sh-NR2F1-3 lentivirus. n = 3 per group; mean ± standard deviation; ∗∗∗ p < 0.001; one-way ANOVA. (H–K) The protein expression and quantitative graphs of FN1, VIM, and α-SMA in TGF-β1-induced SRA01/04 cells with Sh-NC or Sh-NR2F1. n = 3 per group; mean ± standard deviation; ∗ p < 0.05, ∗∗ p < 0.01; unpaired student's t -test. (L – N) Immunofluorescence images of FN1, VIM, and α-SMA in TGF-β1-mediated SRA01/04 cells with Sh-NC or Sh-NR2F1. Scale bar, 100 μm. NR2F1, nuclear receptor subfamily 2 group F member 1; ASC, anterior subcapsular cataract; FN1, fibronectin 1; α-SMA, α-smooth muscle actin; VIM, vimentin; TGF-β1, transforming growth factor-β1.

Article Snippet: NR2F1 agonist 1 (HY-149913, MCE) was treated at 0.5 or 1 μM concentration.

Techniques: Knockdown, In Vivo, In Vitro, Negative Control, Injection, Staining, Immunofluorescence, Transfection, Standard Deviation, Expressing

NR2F1 inhibition suppresses epithelial cell apoptosis and migration. (A) The TUNEL staining in lens sections of AAV-NC and AAV-NR2F1 mice with ASC. Scale bar: 50 μm. (B – D) The protein levels and quantitative charts of BAX and CASP3 in the two groups mentioned above. n = 3 per group; mean ± standard deviation; ∗ p < 0.05, ∗∗ p < 0.01; unpaired student's t -test. (E, F) The TUNEL staining in the TGF-β1-mediated group with Sh-NR2F1 compared with that with Sh-NC. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test; scale bar, 200 μm. (G – I) The protein expression and quantification of BAX and CASP3 in TGF-β1-induced SRA01/04 cells with or without Sh-NR2F1. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. (J, K) The transwell assay in the two groups mentioned above. n = 4 per group; mean ± standard deviation; ∗∗ p < 0.01; unpaired student's t -test. (I–K) The protein expression and quantification of BAX and CASP3 in TGF-β1-induced SRA01/04 cells with or without Sh-NR2F1. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. NR2F1, nuclear receptor subfamily 2 group F member 1; AAV, adeno-associated adenovirus; ASC, anterior subcapsular cataract; BAX, Bcl-2-associated X; CASP3, caspase 3; TGF-β1, transforming growth factor-β1.

Journal: Genes & Diseases

Article Title: Autophagy-induced NR2F1 activation promotes the apoptosis of lens epithelial cells and facilitates cataract-associated fibrosis through targeting STAT3

doi: 10.1016/j.gendis.2025.101549

Figure Lengend Snippet: NR2F1 inhibition suppresses epithelial cell apoptosis and migration. (A) The TUNEL staining in lens sections of AAV-NC and AAV-NR2F1 mice with ASC. Scale bar: 50 μm. (B – D) The protein levels and quantitative charts of BAX and CASP3 in the two groups mentioned above. n = 3 per group; mean ± standard deviation; ∗ p < 0.05, ∗∗ p < 0.01; unpaired student's t -test. (E, F) The TUNEL staining in the TGF-β1-mediated group with Sh-NR2F1 compared with that with Sh-NC. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test; scale bar, 200 μm. (G – I) The protein expression and quantification of BAX and CASP3 in TGF-β1-induced SRA01/04 cells with or without Sh-NR2F1. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. (J, K) The transwell assay in the two groups mentioned above. n = 4 per group; mean ± standard deviation; ∗∗ p < 0.01; unpaired student's t -test. (I–K) The protein expression and quantification of BAX and CASP3 in TGF-β1-induced SRA01/04 cells with or without Sh-NR2F1. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; unpaired student's t -test. NR2F1, nuclear receptor subfamily 2 group F member 1; AAV, adeno-associated adenovirus; ASC, anterior subcapsular cataract; BAX, Bcl-2-associated X; CASP3, caspase 3; TGF-β1, transforming growth factor-β1.

Article Snippet: NR2F1 agonist 1 (HY-149913, MCE) was treated at 0.5 or 1 μM concentration.

Techniques: Inhibition, Migration, TUNEL Assay, Staining, Standard Deviation, Expressing, Transwell Assay

NR2F1 directly binds to STAT3 and regulates the expression of p-STAT3. (A, B) The protein levels and quantification of JAK1, p-STAT3, SMAD2, and MYD88 in TGF-β1-treated SRA01/04 cells with or without Sh-NR2F1. n = 3 per group; mean ± standard deviation; ns, >0.05; ∗∗ p < 0.01; unpaired student's t -test. (C, D) The protein level and quantitative chart of p-STAT3 in AAV-NC or AAV-NR2F1 ASC mice. n = 3 per group; mean ± standard deviation; ∗ p < 0.01; unpaired student's t -test. (E) The motif of NR2F1 predicted by the JASPAR website. (F) A dual-luciferase vector. (G) Mutant and wild-type STAT3 plasmids consequences. (H) The dual-luciferase assay for NR2F1 and STAT3 promoter. n = 3 per group; mean ± standard deviation; ns, >0.05; ∗ p < 0.05; unpaired student's t -test. (I, J) The protein level of p-STAT3 in TGF-β1-induced SRA01/04 cells following NR2F1 agonist treatment at 0.5 or 1 μM. n = 3 per group; mean ± standard deviation; ns > 0.05; ∗ p < 0.05; one-way ANOVA. (K) Structure of p-STAT3 specific inhibitor NSC 74859. (L, M) The protein expression and quantification of p-STAT3, STAT3, JAK1, FN1, VIM, and α-SMA in TGF-β1-induced SRA01/04 cells treated with the specific P-STAT3 inhibitor. n = 3 per group; mean ± standard deviation; ns, >0.05, ∗ p < 0.05, ∗∗ p < 0.01; one-way ANOVA. (N, O) The protein expression of the apoptosis-related markers BAX and CASP3 in TGF-β1-induced SRA01/04 cells treated with NSC 74859. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; one-way ANOVA. NR2F1, nuclear receptor subfamily 2 group F member 1; STAT3, signal transducer and activator of transcription 3; p-STAT3, phosphorylated STAT3; ASC, anterior subcapsular cataract; FN1, fibronectin 1; α-SMA, α-smooth muscle actin; VIM, vimentin; BAX, Bcl-2-associated X; CASP3, caspase 3; TGF-β1, transforming growth factor-β1; JAK1, Janus kinase 1; SMAD2, SMAD family member 2; AAV, adeno-associated adenovirus.

Journal: Genes & Diseases

Article Title: Autophagy-induced NR2F1 activation promotes the apoptosis of lens epithelial cells and facilitates cataract-associated fibrosis through targeting STAT3

doi: 10.1016/j.gendis.2025.101549

Figure Lengend Snippet: NR2F1 directly binds to STAT3 and regulates the expression of p-STAT3. (A, B) The protein levels and quantification of JAK1, p-STAT3, SMAD2, and MYD88 in TGF-β1-treated SRA01/04 cells with or without Sh-NR2F1. n = 3 per group; mean ± standard deviation; ns, >0.05; ∗∗ p < 0.01; unpaired student's t -test. (C, D) The protein level and quantitative chart of p-STAT3 in AAV-NC or AAV-NR2F1 ASC mice. n = 3 per group; mean ± standard deviation; ∗ p < 0.01; unpaired student's t -test. (E) The motif of NR2F1 predicted by the JASPAR website. (F) A dual-luciferase vector. (G) Mutant and wild-type STAT3 plasmids consequences. (H) The dual-luciferase assay for NR2F1 and STAT3 promoter. n = 3 per group; mean ± standard deviation; ns, >0.05; ∗ p < 0.05; unpaired student's t -test. (I, J) The protein level of p-STAT3 in TGF-β1-induced SRA01/04 cells following NR2F1 agonist treatment at 0.5 or 1 μM. n = 3 per group; mean ± standard deviation; ns > 0.05; ∗ p < 0.05; one-way ANOVA. (K) Structure of p-STAT3 specific inhibitor NSC 74859. (L, M) The protein expression and quantification of p-STAT3, STAT3, JAK1, FN1, VIM, and α-SMA in TGF-β1-induced SRA01/04 cells treated with the specific P-STAT3 inhibitor. n = 3 per group; mean ± standard deviation; ns, >0.05, ∗ p < 0.05, ∗∗ p < 0.01; one-way ANOVA. (N, O) The protein expression of the apoptosis-related markers BAX and CASP3 in TGF-β1-induced SRA01/04 cells treated with NSC 74859. n = 3 per group; mean ± standard deviation; ∗ p < 0.05; one-way ANOVA. NR2F1, nuclear receptor subfamily 2 group F member 1; STAT3, signal transducer and activator of transcription 3; p-STAT3, phosphorylated STAT3; ASC, anterior subcapsular cataract; FN1, fibronectin 1; α-SMA, α-smooth muscle actin; VIM, vimentin; BAX, Bcl-2-associated X; CASP3, caspase 3; TGF-β1, transforming growth factor-β1; JAK1, Janus kinase 1; SMAD2, SMAD family member 2; AAV, adeno-associated adenovirus.

Article Snippet: NR2F1 agonist 1 (HY-149913, MCE) was treated at 0.5 or 1 μM concentration.

Techniques: Expressing, Standard Deviation, Luciferase, Plasmid Preparation, Mutagenesis

The regulatory mechanism of NR2F1 in TGF-β1-induced SRA01/04 cells. NR2F1, nuclear receptor subfamily 2 group F member 1; TGF-β1, transforming growth factor-β1.

Journal: Genes & Diseases

Article Title: Autophagy-induced NR2F1 activation promotes the apoptosis of lens epithelial cells and facilitates cataract-associated fibrosis through targeting STAT3

doi: 10.1016/j.gendis.2025.101549

Figure Lengend Snippet: The regulatory mechanism of NR2F1 in TGF-β1-induced SRA01/04 cells. NR2F1, nuclear receptor subfamily 2 group F member 1; TGF-β1, transforming growth factor-β1.

Article Snippet: NR2F1 agonist 1 (HY-149913, MCE) was treated at 0.5 or 1 μM concentration.

Techniques:

Kinase domain constructs with yields >2 μ g/mL culture for 96-kinase expression screen. Kinases are listed by Uniprot designation and whether they were co-expressed with  Lambda  or truncated YopH164 phosphatase. Yield (determined by Caliper GX II quantitation of the expected size band) reported in μ g/mL culture, where total eluate volume was 120 μ L from 900 μ L bacterial culture. Yields are shaded green (yield > 12 μ g/mL), yellow (12 > yield > 7 μ g/mL) and orange (yield <7 μ g/mL); kinase domain constructs with yields that were undetectable or < 2 μ g/mL are not listed. ‡ denotes that the second kinase domain of KS6A1_HUMAN was expressed; all other kinases were the first or only kinase domain occurring in the ORF. Construct boundaries are listed in UniProt residue numbering for the UniProt canonical isoform. An interactive table of expression yields and corresponding constructs is available at http://choderalab.org/kinome-expression

Journal: Biochemistry

Article Title: An open library of human kinase domain constructs for automated bacterial expression

doi: 10.1021/acs.biochem.7b01081

Figure Lengend Snippet: Kinase domain constructs with yields >2 μ g/mL culture for 96-kinase expression screen. Kinases are listed by Uniprot designation and whether they were co-expressed with Lambda or truncated YopH164 phosphatase. Yield (determined by Caliper GX II quantitation of the expected size band) reported in μ g/mL culture, where total eluate volume was 120 μ L from 900 μ L bacterial culture. Yields are shaded green (yield > 12 μ g/mL), yellow (12 > yield > 7 μ g/mL) and orange (yield <7 μ g/mL); kinase domain constructs with yields that were undetectable or < 2 μ g/mL are not listed. ‡ denotes that the second kinase domain of KS6A1_HUMAN was expressed; all other kinases were the first or only kinase domain occurring in the ORF. Construct boundaries are listed in UniProt residue numbering for the UniProt canonical isoform. An interactive table of expression yields and corresponding constructs is available at http://choderalab.org/kinome-expression

Article Snippet: MK03_HUMAN , 1–379 , Addgene 23509 , Lambda , 36.4.

Techniques: Construct, Expressing, Quantitation Assay, Residue, Plasmid Preparation

Figure 1. NR2F1 is downstream of p38 and HER2 signaling in ECCs. A. QPCR and percentage of cells/duct with nuclear NR2F1 shown by IHC from mammary glands of MMTV-HER2 females treated with SB203580. N=2 mice/condition. B. Percentage of HER2 positive+ cells per field of view (FOV) that has either NR2F1HIGH

Journal: Cancer research

Article Title: NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.

doi: 10.1158/0008-5472.CAN-21-4145

Figure Lengend Snippet: Figure 1. NR2F1 is downstream of p38 and HER2 signaling in ECCs. A. QPCR and percentage of cells/duct with nuclear NR2F1 shown by IHC from mammary glands of MMTV-HER2 females treated with SB203580. N=2 mice/condition. B. Percentage of HER2 positive+ cells per field of view (FOV) that has either NR2F1HIGH

Article Snippet: Acini were also transduced with shRNA against mouse Nr2f1 gene (Origene #TL516691C and #TL516691D), or controlshRNA (Origene #TR30021, non-effective scrambled shRNA).

Techniques:

Figure 2. NR2F1 inhibits MMTV-HER2 ECCs invasion. A. Percentage of invading cells with high/low NR2F1 reporter activity in acini by IF. Arrows show invading cells. B. Schematic of invasive protrusions and length-over-width (L/W) ratio. C&D. Time lapse imaging of siControl (C) or siNR2F1 (D) acini. E. L/W ratio of protrusions in siControl (black) or siNr2f1 (blue) acini. F. Percentage of invasive and non-invasive protrusions in siControl and siNr2f1 in acini. N=2. Fisher’s exact test. G. Migration assay for NR2F1-overexpressing or empty vector control MMTV-HER2 ECCs. N=2. H. Schematic of intravital imaging using mammary gland windows (Adapted[19]). I&J. Percentage of acinar structures with outward invasion (J) by intravital imaging (I) in mice orthotopically injected with shControl or shNr2f1 MMTV-HER2 ECCs. N=3-4mice/

Journal: Cancer research

Article Title: NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.

doi: 10.1158/0008-5472.CAN-21-4145

Figure Lengend Snippet: Figure 2. NR2F1 inhibits MMTV-HER2 ECCs invasion. A. Percentage of invading cells with high/low NR2F1 reporter activity in acini by IF. Arrows show invading cells. B. Schematic of invasive protrusions and length-over-width (L/W) ratio. C&D. Time lapse imaging of siControl (C) or siNR2F1 (D) acini. E. L/W ratio of protrusions in siControl (black) or siNr2f1 (blue) acini. F. Percentage of invasive and non-invasive protrusions in siControl and siNr2f1 in acini. N=2. Fisher’s exact test. G. Migration assay for NR2F1-overexpressing or empty vector control MMTV-HER2 ECCs. N=2. H. Schematic of intravital imaging using mammary gland windows (Adapted[19]). I&J. Percentage of acinar structures with outward invasion (J) by intravital imaging (I) in mice orthotopically injected with shControl or shNr2f1 MMTV-HER2 ECCs. N=3-4mice/

Article Snippet: Acini were also transduced with shRNA against mouse Nr2f1 gene (Origene #TL516691C and #TL516691D), or controlshRNA (Origene #TR30021, non-effective scrambled shRNA).

Techniques: Activity Assay, Imaging, Migration, Plasmid Preparation, Control, Injection

Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV- HER2 ECC acini. A. QPCR for the indicated genes in siControl vs. siNr2f1 MMTV-HER2 ECC acini. N=3-9. B. Percentage of E-cadherin+ acini by IF. N=3. C. Percentage of TWIST1+ cells per acinus. N=2. D. Percentage of PRRX1+ acini by IF. N=2. E. IF staining for NR2F1 (green), PRRX1 (red) and panCK (gray) in HER2− (n=6), HER2+ (n=7) and benign adjacent (n=6) DCIS samples. Representative images for PRRX1 levels are shown (left). Representative cell with NR2F1LOW/PRRX1HIGH signature is shown (middle). Fisher’s exact test. F. Percentage of β-catenin+ MMTV-HER2 ECC acini by IF after transfection with siRNA. N=2. G. Percentage of β-catenin+ acini after transfection with siNr2f1#2 and treatment with rDKK1.

Journal: Cancer research

Article Title: NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.

doi: 10.1158/0008-5472.CAN-21-4145

Figure Lengend Snippet: Figure 3. NR2F1 depletion allows a partial EMT and hybrid luminal/basal program in MMTV- HER2 ECC acini. A. QPCR for the indicated genes in siControl vs. siNr2f1 MMTV-HER2 ECC acini. N=3-9. B. Percentage of E-cadherin+ acini by IF. N=3. C. Percentage of TWIST1+ cells per acinus. N=2. D. Percentage of PRRX1+ acini by IF. N=2. E. IF staining for NR2F1 (green), PRRX1 (red) and panCK (gray) in HER2− (n=6), HER2+ (n=7) and benign adjacent (n=6) DCIS samples. Representative images for PRRX1 levels are shown (left). Representative cell with NR2F1LOW/PRRX1HIGH signature is shown (middle). Fisher’s exact test. F. Percentage of β-catenin+ MMTV-HER2 ECC acini by IF after transfection with siRNA. N=2. G. Percentage of β-catenin+ acini after transfection with siNr2f1#2 and treatment with rDKK1.

Article Snippet: Acini were also transduced with shRNA against mouse Nr2f1 gene (Origene #TL516691C and #TL516691D), or controlshRNA (Origene #TR30021, non-effective scrambled shRNA).

Techniques: Staining, Transfection

Figure 4. NR2F1 inhibits systemic dissemination of MMTV-HER2 ECCs. A. Tumor volume measurements in nude mice orthotopically injected with shControl and shNr2f1 MMTV-HER2 ECCs or MMTV-HER2 tumor-derived (PT) cells. B. Percentage of PH3+ cells/acinus in mammary glands orthotopically injected with shControl or shNr2f1 MMTV-HER2 ECCs 10-16 day post-injections. N=2 mice/group. C. Experimental design for detection of eDCCs in nude mice 10-16 days after ortothopic injection with shControl and shNr2f1 MMTV-HER2 ECCs. N=4mice/group. D. Number of eDCCs (HER2+) per lung area as described in C. Number of DCCs= 4,399 shControl; 4,305 shNr2f1. Representative image shown, scale bar=5 μm. E. Percentage of PH3+/HER2+ lung eDCCs as described in C. Number of eDCCs= 4,399 shControl; 4,305 shNr2f1. Image depicts a

Journal: Cancer research

Article Title: NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.

doi: 10.1158/0008-5472.CAN-21-4145

Figure Lengend Snippet: Figure 4. NR2F1 inhibits systemic dissemination of MMTV-HER2 ECCs. A. Tumor volume measurements in nude mice orthotopically injected with shControl and shNr2f1 MMTV-HER2 ECCs or MMTV-HER2 tumor-derived (PT) cells. B. Percentage of PH3+ cells/acinus in mammary glands orthotopically injected with shControl or shNr2f1 MMTV-HER2 ECCs 10-16 day post-injections. N=2 mice/group. C. Experimental design for detection of eDCCs in nude mice 10-16 days after ortothopic injection with shControl and shNr2f1 MMTV-HER2 ECCs. N=4mice/group. D. Number of eDCCs (HER2+) per lung area as described in C. Number of DCCs= 4,399 shControl; 4,305 shNr2f1. Representative image shown, scale bar=5 μm. E. Percentage of PH3+/HER2+ lung eDCCs as described in C. Number of eDCCs= 4,399 shControl; 4,305 shNr2f1. Image depicts a

Article Snippet: Acini were also transduced with shRNA against mouse Nr2f1 gene (Origene #TL516691C and #TL516691D), or controlshRNA (Origene #TR30021, non-effective scrambled shRNA).

Techniques: Injection, Derivative Assay

Figure 5. Graphical summary. Our data suggest that p38 inactivity reduces NR2F1 levels in normal mammary epithelial cells (left) and MMTV-HER2 ECCs (right). In the latter scenario, NR2F1 downregulation led to a partial EMT, a shift β-catenin localization from membrane to nuclei and a hybrid luminal/basal phenotype allowing dissemination of ECCs to distant organs. Thus, NR2F1 acts as a barrier for early dissemination and its loss in early lesions could indicate the presence of early disseminated cancer cells (eDCCs). Image by Jill Gregory. Used with permission of ©Mount Sinai Health System.

Journal: Cancer research

Article Title: NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.

doi: 10.1158/0008-5472.CAN-21-4145

Figure Lengend Snippet: Figure 5. Graphical summary. Our data suggest that p38 inactivity reduces NR2F1 levels in normal mammary epithelial cells (left) and MMTV-HER2 ECCs (right). In the latter scenario, NR2F1 downregulation led to a partial EMT, a shift β-catenin localization from membrane to nuclei and a hybrid luminal/basal phenotype allowing dissemination of ECCs to distant organs. Thus, NR2F1 acts as a barrier for early dissemination and its loss in early lesions could indicate the presence of early disseminated cancer cells (eDCCs). Image by Jill Gregory. Used with permission of ©Mount Sinai Health System.

Article Snippet: Acini were also transduced with shRNA against mouse Nr2f1 gene (Origene #TL516691C and #TL516691D), or controlshRNA (Origene #TR30021, non-effective scrambled shRNA).

Techniques: Membrane

Figure 1. Immunohistochemical analysis of Shh pathway expression in human brain AVMs. Representative images of human brain AVMs and control brain vessels. Cells in the intimal layer of AVMs are strongly immunopositive for Shh and Gli1. COUP-TFII immunopositive cells are detectable in the intimal and medial layers of AVMs. Control brain vessels are negative in terms of Shh, Gli1, and COUP-TFII expression. Shh: Sonic hedgehog.

Journal: Journal of Cerebral Blood Flow & Metabolism

Article Title: Sonic hedgehog is expressed in human brain arteriovenous malformations and induces arteriovenous malformations in vivo

doi: 10.1177/0271678x20912405

Figure Lengend Snippet: Figure 1. Immunohistochemical analysis of Shh pathway expression in human brain AVMs. Representative images of human brain AVMs and control brain vessels. Cells in the intimal layer of AVMs are strongly immunopositive for Shh and Gli1. COUP-TFII immunopositive cells are detectable in the intimal and medial layers of AVMs. Control brain vessels are negative in terms of Shh, Gli1, and COUP-TFII expression. Shh: Sonic hedgehog.

Article Snippet: For the detection of COUP-TFII expression in brain vasculature, sections were incubated with lectin from Lycopersicon esculentum (tomato) biotin conjugate (1:500) (SigmaAldrich, St. Louis, MO, USA) together with a rabbit polyclonal anti-COUP-TFII antibody (Origene, Rockville, MD, USA).

Techniques: Immunohistochemical staining, Expressing, Control

Figure 7. Expression of COUP-TFII in phShh-induced brain neovessels. Sections of brain hemispheres injected with phShh and empty plasmid were stained for DAPI (blue staining) to identify cell nuclei, lectin (red staining) to identify blood vessels, and COUP- TFII (green staining) to identify cells expressing this vascular differentiation marker. (a) COUP-TFII-positive cells were found in the neovessels grown in the brain in response to phShh injection, both at the level of the intimal layer and the vascular wall. (b) COUP- TFII-positive cells were virtually absent in brain hemispheres injected with the empty plasmid.

Journal: Journal of Cerebral Blood Flow & Metabolism

Article Title: Sonic hedgehog is expressed in human brain arteriovenous malformations and induces arteriovenous malformations in vivo

doi: 10.1177/0271678x20912405

Figure Lengend Snippet: Figure 7. Expression of COUP-TFII in phShh-induced brain neovessels. Sections of brain hemispheres injected with phShh and empty plasmid were stained for DAPI (blue staining) to identify cell nuclei, lectin (red staining) to identify blood vessels, and COUP- TFII (green staining) to identify cells expressing this vascular differentiation marker. (a) COUP-TFII-positive cells were found in the neovessels grown in the brain in response to phShh injection, both at the level of the intimal layer and the vascular wall. (b) COUP- TFII-positive cells were virtually absent in brain hemispheres injected with the empty plasmid.

Article Snippet: For the detection of COUP-TFII expression in brain vasculature, sections were incubated with lectin from Lycopersicon esculentum (tomato) biotin conjugate (1:500) (SigmaAldrich, St. Louis, MO, USA) together with a rabbit polyclonal anti-COUP-TFII antibody (Origene, Rockville, MD, USA).

Techniques: Expressing, Injection, Plasmid Preparation, Staining, Marker